Travere Therapeutics (TVTX) drew investor attention on 4 August 2026 after reporting second quarter results that combined ...
Earlier this week, Travere Therapeutics reported Q2 2026 results showing revenue rising to US$169.58 million from US$114.45 ...
Investor's Business Daily on MSN
Stock market rally powers ahead; SpaceX, Palantir, SanDisk are key earnings movers: Weekly review
The S&P 500 and Dow Jones hit highs while the Nasdaq raced above key levels as oil prices and yields fell. Palantir, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results